Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 19, 2023
Customized 3D-printed molds for high dose-rate brachytherapy in facial skin cancer: First clinical experienceGeorgios Chatzikonstantinou, Markus Diefenhardt, Maximilian Fleischmann, et al.Scientific Reports|December 8, 2022
Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single centerMarcus Zimmermann, Anne Richter, Stefan Weick, et al.Journal of Contemporary Brachytherapy|March 2, 2022
Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapyChristian Scherf, Ulla Ramm, Thomas Stein, et al.Journal of Contemporary Brachytherapy|April 26, 2021
Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of viewChristian Scherf, Jörg Licher, Christina Mletzko, et al.Clinical and Translational Radiation Oncology|April 22, 2022
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study groupMaximilian Fleischmann, Markus Diefenhardt, Adele M Nicolas, et al.International Journal of Dermatology|February 27, 2021
HDR brachytherapy with individual epithetic molds for facial skin cancer: techniques and first clinical experienceMarkus Diefenhardt, Georgios Chatzikonstantinou, Markus Meissner, et al.Dermatology and Therapy|November 5, 2025
HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMsMarkus Diefenhardt, Nikolaos Tselis, Julia Achenbach, et al.Cancers|November 26, 2022
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and BrachytherapyMaximilian Fleischmann, Ranadip Mandal, Izabela Kostova, et al.Cancers|August 12, 2022
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints RevisitedMarkus Diefenhardt, Anke Schlenska-Lange, Thomas Kuhnt, et al.Cancers|September 23, 2022
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III TrialMarkus Diefenhardt, Daniel Martin, Ethan B Ludmir, et al.Pageof 4